BIFURCATION ANALYSIS IN A SEROGROUP A MENINGOCOCCAL INFECTION MODEL

被引:1
作者
Bah, Alpha Oumar [1 ]
Lam, Mountaga [1 ]
Bah, Alassane [2 ]
Bowong, Samuel [3 ]
机构
[1] Univ Cheikh Anta Diop, Dept Math, Fac Sci & Tech, Dakar, Senegal
[2] Univ Cheikh Anta Diop, Natl Adv Sch Engn, Dept Comp Engn, Dakar, Senegal
[3] Univ Douala, Fac Sci, Dept Math & Comp Sci, Lab Math, POB 24157, Douala, Cameroon
关键词
epidemiological models; serogroup A meningococcal infection; stability; bifurcation; NEISSERIA-MENINGITIDIS; BACKWARD BIFURCATION; SENSITIVITY-ANALYSIS; VACCINATION; DISEASE; EPIDEMIC; TUBERCULOSIS; W135; TRANSMISSION; UNCERTAINTY;
D O I
10.28919/cmbn/3760
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
A mathematical model is formulated that enables the understanding of the dynamics of the transmission of serogroup A meningococcal (MenA) infection. We provide the theoretical analysis of the model. We compute the basic reproduction number R-0 and shows that the outcome of the disease depends on a threshold parameter xi. More precisely, we show that when R-0 <= xi, the disease-free equilibrium is globally asymptotically stable, while when xi <= R-0 <= 1, the model exhibits the phenomenon of backward bifurcation, when a stable diseasefree equilibrium co-exists with one or more stable endemic equilibria. Sensitivity analysis of the model has been performed in order to determine the impact of related parameters on meningitis outbreak. Random perturbation of the vaccine efficacy was performed to gain insight into the role of the vaccine efficacy on the stability of the disease-free equilibrium. Theoretical results are supported by numerical simulations, which further suggest that the control of the epidemic of MenA pass through a combination of a large coverage vaccination of young susceptible individuals and the production of a vaccine with a high level of efficacy.
引用
收藏
页数:38
相关论文
共 50 条
  • [31] Stability and bifurcation analysis of an epidemic model with the effect of media
    Kar, T. K.
    Nandi, Swapan Kumar
    Jana, Soovoojeet
    Mandal, Manotosh
    CHAOS SOLITONS & FRACTALS, 2019, 120 (188-199) : 188 - 199
  • [32] Bexsero - A Second Serogroup B Meningococcal Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1482): : 158 - 159
  • [33] Child with serogroup W135 primary meningococcal septic arthritis
    Fidder, A. R.
    de Hartog, Bas
    Faber, Tina
    BMJ CASE REPORTS, 2019, 12 (10)
  • [34] Toward an Improved Meningococcal Serogroup B Assay
    Poolman, Jan
    MBIO, 2018, 9 (03):
  • [35] Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review
    Nwogu, Ifechukwu B.
    Jones, Matthew
    Langley, Tessa
    VACCINE, 2021, 39 (16) : 2201 - 2213
  • [36] Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada
    Tu, Hong Anh T.
    Deeks, Shelley L.
    Morris, Shaun K.
    Strifler, Lisa
    Crowcroft, Natasha
    Jamieson, Frances B.
    Kwong, Jeffrey C.
    Coyte, Peter C.
    Krahn, Murray
    Sander, Beate
    VACCINE, 2014, 32 (42) : 5436 - 5446
  • [37] Serogroup a meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies
    Sherman, Amy C.
    Stephens, David S.
    EXPERT REVIEW OF VACCINES, 2020, 19 (05) : 455 - 463
  • [38] Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy
    Morrone, Teresa
    Napolitano, Francesco
    Albano, Luciana
    Di Giuseppe, Gabriella
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1921 - 1927
  • [39] Bifurcation analysis of macrophages infection model with delayed immune response
    Prakash, M.
    Balasubramaniam, P.
    COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2016, 35 : 1 - 16
  • [40] The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
    Bettinger, Julie A.
    Scheifele, David W.
    Le Saux, Nicole
    Halperin, Scott A.
    Vaudry, Wendy
    Tsang, Raymond
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (03) : 220 - 224